Numab Therapeutics News and Activities

View the org chart displaying its 18 main executives

Most searched biographies at Numab Therapeutics

• Angehrn Pavik, Chief Executive Officer
• Michael Bauer, Director
• Carlo Incerti, Chairman of the Board

Popular executive movements at Numab Therapeutics

• Angehrn Pavik has joined the company as Chief Executive Officer  (posted on September 9 2025).
• David Urech who was Chief Executive Officer, becomes Director  (posted on September 9 2025).

Create your alert
to follow the executive moves at Numab Therapeutics.

Numab Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Numab Therapeutics

• Numab Therapeutics AG

Social media about Numab Therapeutics

• Numab Therapeutics on Wikipedia, Google News & Yahoo Finance
• Numab Therapeutics on LinkedIn, X (Twitter) & YouTube